ArticleCancer immunology, immunotherapy : CII2014

Phase I trial of a recombinant yeast-CEA vaccine (GI-6207) in adults with metastatic CEA-expressing carcinoma.

Marijo Bilusic et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.